Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 267 results

Search term: MF = 'C_{29}H_{35}ClN_{2}O_{3}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
40784

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H34N2O3.ClH/c1-2-27(34-28(32)23-13-15-26(30)16-14-23)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)17-18-31-19-21-33-22-20-31;/h3-16,27H,2,17-22,30H2,1H3;1H
C29H35ClN2O3495.052811900
329216
InChI=1/C29H35ClN2O3/c1-31(2)18-20-34-26-14-6-22(7-15-26)28(29(30)24-10-12-25(33-5)13-11-24)23-8-16-27(17-9-23)35-21-19-32(3)4/h6-17H,18-21H2,1-5H3
C29H35ClN2O3495.05288400
58174705

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H35ClN2O3/c1-19-22-16-25(30)27(33)24(28(22)35-29(34)23(19)15-20-9-4-3-5-10-20)18-31(2)17-21-11-8-14-32-13-7-6-12-26(21)32/h3-5,9-10,16,21,26,33H,6-8,11-15,17-18H2,1-2H3/t21-,26+/m0/s1
C29H35ClN2O3495.05287400
68104983

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C29H35ClN2O3/c1-19-22-16-25(30)27(33)24(28(22)35-29(34)23(19)15-20-9-4-3-5-10-20)18-31(2)17-21-11-8-14-32-13-7-6-12-26(21)32/h3-5,9-10,16,21,26,33H,6-8,11-15,17-18H2,1-2H3
C29H35ClN2O3495.05287700
58173285

3 of 4 defined stereocentres - 3/4 defined
InChI=1/C29H35ClN2O3/c30-24-14-22-20-7-1-2-8-21(20)29(34)35-28(22)23(27(24)33)16-32-11-5-6-17-12-18-13-19(26(17)32)15-31-10-4-3-9-25(18)31/h12,14,18-19,25-26,33H,1-11,13,15-16H2/t18-,19?,25+,26+/m0/s1
C29H35ClN2O3495.05286500
58539640

1 of 4 defined stereocentres - 1/4 defined
InChI=1/C29H35ClN2O3/c30-24-14-22-20-7-1-2-8-21(20)29(34)35-28(22)23(27(24)33)16-32-11-5-6-17-12-18-13-19(26(17)32)15-31-10-4-3-9-25(18)31/h12,14,18-19,25-26,33H,1-11,13,15-16H2/t18-,19?,25?,26?/m0/s1
C29H35ClN2O3495.05286300
2127213

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C29H34N2O3.ClH/c1-3-18-31(22(2)14-15-23-10-6-4-7-11-23)20-27(32)25-16-17-28(26(19-25)29(30)33)34-21-24-12-8-5-9-13-24;/h3-13,16-17,19,22,27,32H,1,14-15,18,20-21H2,2H3,(H2,30,33);1H
C29H35ClN2O3495.05286500
81424401

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H34N2O3.ClH/c1-20-10-12-21(13-11-20)14-15-25-24-19-27(34-4)26(33-3)18-23(24)16-17-31(25)28(29(32)30-2)22-8-6-5-7-9-22;/h5-13,18-19,25,28H,14-17H2,1-4H3,(H,30,32);1H/t25-,28+;/m0./s1
C29H35ClN2O3495.05285400
2317993
InChI=1/C29H32N2O2.ClH.H2O/c32-28(33)17-7-5-3-1-2-4-6-12-22-18-20-23(21-19-22)30-29-24-13-8-10-15-26(24)31-27-16-11-9-14-25(27)29;;/h8-11,13-16,18-21H,1-7,12,17H2,(H,30,31)(H,32,33);1H;1H2
C29H35ClN2O3495.05284200
23017491

Double-bond stereo

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C29H35ClN2O3/c1-18-7-6-8-23(19(18)2)31-27(33)17-32-24-16-21(29(3,4)5)11-14-25(24)35-26(28(32)34)15-20-9-12-22(30)13-10-20/h9-16,18-19,23H,6-8,17H2,1-5H3,(H,31,33)/b26-15+
C29H35ClN2O3495.05284300
12024791

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H35ClN2O3/c1-7-31(8-2)14-9-15-32-25(19-10-12-20(13-11-19)29(4,5)6)24-26(33)21-17-22(30)18(3)16-23(21)35-27(24)28(32)34/h10-13,16-17,25H,7-9,14-15H2,1-6H3
C29H35ClN2O3495.05283300
22723224

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H35ClN2O3/c1-22-19-25(9-11-27(22)30)35-29(26-20-24(33-2)10-12-28(26)34-3)13-14-31-15-17-32(18-16-31)21-23-7-5-4-6-8-23/h4-12,19-20,29H,13-18,21H2,1-3H3
C29H35ClN2O3495.05283200
26347215

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H35ClN2O3/c1-33-26-10-8-23(9-11-26)27-20-32(14-13-21-7-12-28(34-2)29(16-21)35-3)19-24(27)18-31-17-22-5-4-6-25(30)15-22/h4-12,15-16,24,27,31H,13-14,17-20H2,1-3H3/t24-,27+/m0/s1
C29H35ClN2O3495.05283300
2791796

Double-bond stereo

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C29H35ClN2O3/c1-18-7-6-8-23(19(18)2)31-27(33)17-32-24-16-21(29(3,4)5)11-14-25(24)35-26(28(32)34)15-20-9-12-22(30)13-10-20/h9-16,18-19,23H,6-8,17H2,1-5H3,(H,31,33)
C29H35ClN2O3495.05283200
113604251

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H35ClN2O3/c1-21(2)19-34-26-15-29(28(33)32(18-26)16-22-8-10-24(30)11-9-22)12-5-13-31(20-29)17-25-14-23-6-3-4-7-27(23)35-25/h3-4,6-11,14,21,26H,5,12-13,15-20H2,1-2H3/t26-,29+/m0/s1
C29H35ClN2O3495.05283300
8227020

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C29H35ClN2O3/c1-19(2)29-28(33)27-25(9-6-10-26(27)35-29)34-14-4-3-13-32-23-11-12-24(32)17-22(16-23)31-18-20-7-5-8-21(30)15-20/h5-10,15,22-24,31H,3-4,11-14,16-18H2,1-2H3
C29H35ClN2O3495.05282100
8611292
InChI=1/C29H35ClN2O3/c1-35-28-10-7-21(15-25(28)29(33)34)17-31-13-11-22(12-14-31)26-19-32(18-20-5-3-2-4-6-20)27-9-8-23(30)16-24(26)27/h7-10,15-16,19-20,22H,2-6,11-14,17-18H2,1H3,(H,33,34)
C29H35ClN2O3495.05282100
9595425

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C29H35ClN2O3/c1-18(2)27-29(34)32(24-14-8-10-19-9-6-7-13-22(19)24)26(23-17-20(30)15-16-25(23)35-27)28(33)31-21-11-4-3-5-12-21/h6-7,9,13,15-18,21,24,26-27H,3-5,8,10-12,14H2,1-2H3,(H,31,33)
C29H35ClN2O3495.05282100
28484498

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H34N2O3.ClH/c1-23-9-5-7-13-27(23)31-19-17-30(18-20-31)21-25(32)22-34-29-14-8-6-12-26(29)28(33)16-15-24-10-3-2-4-11-24;/h2-14,25,32H,15-22H2,1H3;1H
C29H35ClN2O3495.05282200
25029199
InChI=1/C29H35ClN2O3/c1-3-34-28-18-21(2)6-11-26(28)22-12-16-32(17-13-22)15-5-4-14-31-29(33)24-19-27(35-20-24)23-7-9-25(30)10-8-23/h6-11,18-20,22H,3-5,12-17H2,1-2H3,(H,31,33)
C29H35ClN2O3495.05282200
12345

Advertisement